Liposomal iron dramatic effect on chronic kidney disease pediatric anemia: a randomized clinical trial
The key message of our article is to determine a safe, effective, easy to use, and less costly treatment of chronic kidney disease anemia in pediatrics. Our study will add to the existing literature a suggestion of an effective and safe treatment for pediatric chronic disorder, the traditional treatment has a lot of serious side effects. The impact of our study is to treat anemia resulted from chronic kidney disease in pediatrics with oral drug that has higher efficacy than the traditional injectable drug, this will lead to higher rate of anemia treatment due to higher rate of children compliance.
Authors
- Mohamed Shokry Elharoun
- Sahar K. Hegazy (ORCID: https://orcid.org/0000-0002-4516-926X)
- M. Koura (ORCID: https://orcid.org/0000-0003-1398-7492)
Institutions
- Tanta University (EG)
- Tanta University Hospital (EG)
- Menoufia University (EG)
Publication Details
- Journal
- Pediatric Research
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1038/s41390-025-04418-x
- Citations
- 1
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Science and Technology Development Fund